Bergel, C. C., Eryilmaz, I. E., Cecener, G., Egeli, U. (2025). Second-generation BRAF inhibitor Encorafenib resistance is regulated by NCOA4-mediated iron trafficking in the drug-resistant malignant melanoma cells. Scientific Reports. https://doi.org/10.1038/s41598-025-86874-3